|
GB201906867D0
|
|
Combination therapy
|
|
GB201906864D0
|
|
Combination therapy
|
|
GB201906873D0
|
|
Combination therapy
|
|
GB201906862D0
|
|
Combination therapy
|
|
CN110996931A
|
|
Compositions and methods for treating fibrotic diseases
|
|
GB201807892D0
|
|
Processes in the preparation of polyunsaturated ketone compounds
|
|
GB201806663D0
|
|
2-Oxothiazole compositions for treatment of fibrotic disease
|
|
GB201806661D0
|
|
Compositions and methods for treatment of a fibrotic disease
|
|
US2019255023A1
|
|
Combination therapy comprising a thiazole and a corticosteroid to treat skin conditions
|
|
KR20190082265A
|
|
Combination therapy comprising thiazoles and cecos steroids for treating skin conditions
|
|
WO2018055062A1
|
|
Pharmaceutical composition
|
|
GB201709671D0
|
|
Compositions and methods for treatment of a fibrotic disease
|
|
KR20190013845A
|
|
Combination Therapy Including Polyunsaturated Ketones and Secoceroids
|
|
CN109310770A
|
|
Conjoint therapy comprising how unsaturated ketone and calcineurin inhibitors
|
|
WO2017207821A1
|
|
Combination therapy comprising a polyunsaturated ketone and a corticosteroid
|
|
GB201708329D0
|
|
Pharmaceutical composition
|
|
GB201708328D0
|
|
Pharmaceutical composition
|
|
GB201704279D0
|
|
Combination therapy
|
|
GB201704281D0
|
|
Combination therapy
|
|
GB201704286D0
|
|
Combination Therapy
|
